Continental Advisors’s Elevance Health ELV Stock Holding History

Continental Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,000	Closed	-$1.26M	–	157
2015 Q3	$1.26M	Sell	9,000 -7,000	-44%	-$1.05M	0.34%	88
2015 Q2	$2.63M	Buy	+16,000	New	+$2.56M	0.7%	52
2014 Q4	–	Sell	-20,000	Closed	-$2.39M	–	156
2014 Q3	$2.39M	Sell	20,000 -45,000	-69%	-$5.16M	0.54%	55
2014 Q2	$7M	Buy	65,000 +60,000	+1,200%	+$6.18M	1.63%	11
2014 Q1	$498K	Buy	+5,000	New	+$452K	0.13%	109
2013 Q4	–	Sell	-10,000	Closed	-$836K	–	145
2013 Q3	$836K	Sell	10,000 -30,000	-75%	-$2.57M	0.21%	105
2013 Q2	$3.27M	Buy	+40,000	New	+$2.99M	0.92%	31

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Continental Advisors's ELV Position: Q3 2014 in Review

Continental Advisors sold out of Elevance Health (ELV) in Q3 2014, closing a stake of 500 shares — an estimated $57.4K sold.

Continental Advisors first reported a position in ELV in Q2 2013 and held it in 3 quarters. The position peaked at $1.64M in Q2 2013. 706 funds tracked by Wall St. Rank hold ELV as of Q3 2014.

Continental Advisors reported no remaining Elevance Health position as of Q3 2014 after selling out during the quarter.
Continental Advisors sold 500 Elevance Health shares in Q3 2014, an estimated $57.4K.
Continental Advisors first reported a position in Elevance Health in Q2 2013 and held it in 3 quarters.
Continental Advisors's Elevance Health position peaked at $1.64M in Q2 2013.
706 funds tracked by Wall St. Rank held Elevance Health as of Q3 2014.

Based on Continental Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.